메뉴 건너뛰기




Volumn 61, Issue 1, 2012, Pages 107-109

Taming the cannabinoids: New potential in the pharmacologic control of lower urinary tract dysfunction

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID 2 RECEPTOR AGONIST; CANNABIS; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

EID: 82255179350     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.09.025     Document Type: Editorial
Times cited : (11)

References (16)
  • 1
    • 0030740514 scopus 로고    scopus 로고
    • The perceived effects of smoked cannabis on patients with multiple sclerosis
    • P. Consroe, R. Musty, J. Rein, W. Tillery, and R. Pertwee The perceived effects of smoked cannabis on patients with multiple sclerosis Eur Neurol 38 1997 44 48 (Pubitemid 27283078)
    • (1997) European Neurology , vol.38 , Issue.1 , pp. 44-48
    • Consroe, P.1    Musty, R.2    Rein, J.3    Tillery, W.4    Pertwee, R.5
  • 2
    • 4344585483 scopus 로고    scopus 로고
    • An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis
    • DOI 10.1191/1352458504ms1063oa
    • C.M. Brady, R. DasGupta, C. Dalton, O.J. Wiseman, K.J. Berkley, and C.J. Fowler An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis Mult Scler 10 2004 425 433 (Pubitemid 39117340)
    • (2004) Multiple Sclerosis , vol.10 , Issue.4 , pp. 425-433
    • Brady, C.M.1    DasGupta, R.2    Dalton, C.3    Wiseman, O.J.4    Berkley, K.J.5    Fowler, C.J.6
  • 4
    • 78349253181 scopus 로고    scopus 로고
    • Randomised controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
    • R. Kavia, D. De Ridder, S. Constantinescu, C.G. Stott, and C.J. Fowler Randomised controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis Mult Scler 16 2010 1349 1359
    • (2010) Mult Scler , vol.16 , pp. 1349-1359
    • Kavia, R.1    De Ridder, D.2    Constantinescu, S.3    Stott, C.G.4    Fowler, C.J.5
  • 5
    • 78650120798 scopus 로고    scopus 로고
    • International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2
    • R.G. Pertwee, A.C. Howlett, and M.E. Abood International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2 Pharmacol Rev 62 2010 588 631
    • (2010) Pharmacol Rev , vol.62 , pp. 588-631
    • Pertwee, R.G.1    Howlett, A.C.2    Abood, M.E.3
  • 6
    • 62049085889 scopus 로고    scopus 로고
    • Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium
    • V. Tyagi, B.J. Philips, and R. Su Differential expression of functional cannabinoid receptors in human bladder detrusor and urothelium J Urol 181 2009 1932 1938
    • (2009) J Urol , vol.181 , pp. 1932-1938
    • Tyagi, V.1    Philips, B.J.2    Su, R.3
  • 7
    • 62049084948 scopus 로고    scopus 로고
    • Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder
    • C. Gratzke, T. Streng, and A. Park Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder J Urol 181 2009 1939 1948
    • (2009) J Urol , vol.181 , pp. 1939-1948
    • Gratzke, C.1    Streng, T.2    Park, A.3
  • 8
    • 78651304302 scopus 로고    scopus 로고
    • Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction
    • C. Gratzke, T. Streng, and C.G. Stief Cannabinor, a selective cannabinoid-2 receptor agonist, improves bladder emptying in rats with partial urethral obstruction J Urol 185 2011 731 736
    • (2011) J Urol , vol.185 , pp. 731-736
    • Gratzke, C.1    Streng, T.2    Stief, C.G.3
  • 9
    • 79955679078 scopus 로고    scopus 로고
    • Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents
    • J.S. Walczak, and F. Cervero Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents Mol Pain 7 2011 31 42
    • (2011) Mol Pain , vol.7 , pp. 31-42
    • Walczak, J.S.1    Cervero, F.2
  • 10
    • 0000713128 scopus 로고    scopus 로고
    • After a decade of intravesical vanilloid therapy: Still more questions than answers
    • DOI 10.1016/S1474-4422(02)00072-8
    • A. Szallasi, and C.J. Fowler After a decade of intravesical vanilloid therapy: still more questions than answers Lancet Neurol 1 2002 167 172 (Pubitemid 37163485)
    • (2002) Lancet Neurology , vol.1 , Issue.3 , pp. 167-172
    • Szallasi, A.1    Fowler, C.J.2
  • 11
    • 82255162759 scopus 로고    scopus 로고
    • Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects by FAAH inhibition on bladder function in awake rats
    • F. Strittmatter, G. Gandaglia, and F. Benigni Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects by FAAH inhibition on bladder function in awake rats Eur Urol 61 2012 98 106
    • (2012) Eur Urol , vol.61 , pp. 98-106
    • Strittmatter, F.1    Gandaglia, G.2    Benigni, F.3
  • 12
    • 77952745545 scopus 로고    scopus 로고
    • Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms
    • 1514 e15-20
    • G. Mukerji, Y. Yiangou, S.K. Agarwal, and P. Anand Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms Urology 75 2010 1514 e15-20
    • (2010) Urology , vol.75
    • Mukerji, G.1    Yiangou, Y.2    Agarwal, S.K.3    Anand, P.4
  • 13
    • 82255170056 scopus 로고    scopus 로고
    • Do cannabinoid agonists used for the treatment of refractory lower urinary tract symptoms in patients with neurogenic detrusor overactivity have an effect on bladder afferent pathways?
    • In press
    • Katafygiotis S, Kavia R, Gonzales G, et al. Do cannabinoid agonists used for the treatment of refractory lower urinary tract symptoms in patients with neurogenic detrusor overactivity have an effect on bladder afferent pathways? Neurourol Urodyn. In press.
    • Neurourol Urodyn.
    • Katafygiotis, S.1    Kavia, R.2    Gonzales, G.3
  • 14
    • 10644266547 scopus 로고    scopus 로고
    • Cannabinoid therapy in detrusor overactivity: Local versus systemic effect in a spinalised rat model
    • W. Blyweert, F. Van Der Aa, and D. De Ridder Cannabinoid therapy in detrusor overactivity: local versus systemic effect in a spinalised rat model Neurourol Urodyn 22 2003 379 380
    • (2003) Neurourol Urodyn , vol.22 , pp. 379-380
    • Blyweert, W.1    Van Der Aa, F.2    De Ridder, D.3
  • 15
    • 52949134790 scopus 로고    scopus 로고
    • Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats
    • F.V. Merriam, Z.Y. Wang, S.D. Guerios, and D.E. Bjorling Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats Neurosci Lett 445 2008 130 134
    • (2008) Neurosci Lett , vol.445 , pp. 130-134
    • Merriam, F.V.1    Wang, Z.Y.2    Guerios, S.D.3    Bjorling, D.E.4
  • 16
    • 77949486271 scopus 로고    scopus 로고
    • Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: Relation to nerves and interstitial cells
    • C. Gratzke, P. Weinhold, and O. Reich Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells Eur Urol 57 2010 902 910
    • (2010) Eur Urol , vol.57 , pp. 902-910
    • Gratzke, C.1    Weinhold, P.2    Reich, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.